Press Release: Enhabit Home Health & Hospice Announces Date of 2025 First Quarter Earnings Call
Is Enhabit, Inc. (EHAB) Stock Outpacing Its Medical Peers This Year?
Kura Sushi Posts Downbeat Results, Joins Cal-Maine Foods And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Why Venus Concept Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket
Enhabit, Inc. Sells Medalogix Stake for $21 Million
Surging Earnings Estimates Signal Upside for Enhabit (EHAB) Stock
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
Enhabit Home Health & Hospice Achieves Level 2 Recognition as an Age-Friendly Health System — Committed to Care Excellence
TD Cowen Maintains Enhabit(EHAB.US) With Hold Rating, Raises Target Price to $9
Oppenheimer Maintains Enhabit(EHAB.US) With Hold Rating
Analysts' Opinions Are Mixed on These Healthcare Stocks: Mind Medicine (MNMD), SurModics (SRDX) and Enhabit, Inc (EHAB)
Express News | Enhabit Inc : Leerink Partners Raises Target Price to $8.5 From $8
Q4 2024 Enhabit Inc Earnings Call
Enhabit, Inc. Reports Q4 Results and 2025 Outlook
Enhabit, Inc. Navigates Growth Amid Challenges
Earnings Call Summary | Enhabit(EHAB.US) Q4 2024 Earnings Conference
Enhabit | 10-K: FY2024 Annual Report
Jefferies Maintains Enhabit(EHAB.US) With Buy Rating, Maintains Target Price $9.5
Enhabit, Inc: Buy Rating Affirmed Amid Growth Potential and Stabilizing Fundamentals
Enhabit Selloff After Q4 Report 'Unwarranted,' Says Jefferies